We read with great interest the Clinician Update by Wolk et al, 1 particularly the paragraph regarding obstructive sleep apnea (OSA). Among the linked-OSA diseases mentioned (hypertension, ischemic heart disease, heart failure, stroke, pulmonary hypertension, cardiac arrhythmias), right-to-left shunting through a patent foramen ovale (PFO) was omitted.
Response
We greatly appreciate the authors' interest in our article. 1 Among cardiovascular conditions related to obstructive sleep apnea (OSA), we discussed hypertension, atherosclerosis, stroke, heart failure, pulmonary hypertension, and cardiac arrhythmias. The manuscript length restrictions did not allow us to mention some other possible associations with OSA, such as metabolic abnormalities (insulin resistance and hyperleptinemia), pulmonary embolism, or deep venous thrombosis. The evidence for any causal link between OSA and these other conditions is still preliminary or inconclusive, warranting further experimental and clinical studies.
The evidence in support of the association between OSA and patent foramen ovale (PFO) is also preliminary, based only on a few studies, the clinical significance of which may be unclear. The original report by Shanoudy et al, 2 which demonstrated an intriguing higher prevalence of PFO in OSA, has some methodological limitations (as discussed by Gossage 3 ). Another study, which showed the presence of right-to-left shunting during single OSA episodes, consisted of only 10 subjects with OSA who were preselected for the presence of right-to-left shunting during the Valsalva maneuver. 4 Although it cannot be excluded that the coexistence of PFO with OSA may exacerbate hypoxemia and hemodynamic consequences of OSA, there is little evidence at present to suggest that the two conditions may be causally related. The authors' recommendation that percutaneous PFO closure should be considered in patients with OSA and right-toleft shunting would certainly merit further investigation. The initial clinical management of such patients should include the treatment of their OSA, which may decrease or even eliminate stress-induced right-to-left shunting.
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